SNC 80

• CAT Number: R002059
• CAS Number: 156727-74-1
• Molecular Formula: C28H39N3O2
• Molecular Weight: 449.64
• Purity: ≥95%
• Target: Opioid Receptor
• Solubility: Soluble in DMSO > 10 mM
• Storage: Store at RT
• IUPAC Name: 4-[(R)-[(2S,5R)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide
• InChI: InChI=1S/C28H39N3O2/c1-7-17-30-19-22(5)31(20-21(30)4)27(25-11-10-12-26(18-25)33-6)23-13-15-24(16-14-23)28(32)29(8-2)9-3/h7,10-16,18,21-22,27H,1,8-9,17,19-20H2,2-6H3/t21-,22+,27-/m1/s1
• InChIKey: KQWVAUSXZDRQPZ-UMTXDNHDSA-N
• SMILES: CCN(CC)C(=O)C1=CC=C(C=C1)C(C2=CC(=CC=C2)OC)N3CC(N(CC3C)CC=C)C

SNC 80（Cat No.:R002059）, also known as (+)-4-[(αR)-α-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-3-methoxybenzyl]-N, N-diethylbenzamide, is a synthetic opioid analgesic drug. It is a selective agonist of the δ-opioid receptor, which is a subtype of opioid receptor that is primarily involved in modulating pain perception. SNC 80 has been studied for its potential use in the treatment of various types of pain, including neuropathic pain and inflammatory pain. It has shown efficacy in preclinical studies and may offer advantages over traditional opioid analgesics, such as reduced tolerance and dependence liability, although further clinical research is needed to confirm these findings.